ORIC ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc. (ORIC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 91% planned / 9% discretionary
Largest single sale: $1.3M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer | Sell 10b5-1 | 77,000 | $13.69 | $1.1M | 69,828 −52.4% of holding | |
| Heyman Richard A. 2 fills | Director | Sell 10b5-1 | 13,100 | $12.02 | $157.5K | 206,672 −6% of holding | |
| Heyman Richard A. | Director | Sell 10b5-1 | 300 | $12.00 | $3.6K | 212,772 −0.1% of holding | |
| Piscitelli Dominic | Chief Financial Officer | Sell 10b5-1 | 52,000 | $13.51 | $702.7K | 68,148 −43.3% of holding | |
| Heyman Richard A. 2 fills | Director | Sell 10b5-1 | 6,700 | $12.00 | $80.4K | 213,072 −3% of holding | |
| Chacko Jacob | PRESIDENT AND CEO | Sell | 33,374 | $9.06 | $302.4K | 581,711 −5.4% of holding | |
| Multani Pratik S | Chief Medical Officer | Sell | 10,720 | $9.06 | $97.1K | 68,149 −13.6% of holding | |
| Piscitelli Dominic | Chief Financial Officer | Sell | 10,720 | $9.06 | $97.1K | 68,148 −13.6% of holding | |
| Chacko Jacob | PRESIDENT AND CEO | Sell 10b5-1 | 37,461 | $12.32 | $461.5K | 531,419 −6.6% of holding | |
| Piscitelli Dominic | Chief Financial Officer | Sell 10b5-1 | 11,000 | $14.52 | $159.7K | 48,317 −18.5% of holding | |
| Chacko Jacob | PRESIDENT AND CEO | Sell 10b5-1 | 53,001 | $12.05 | $638.8K | 568,880 −8.5% of holding | |
| Chacko Jacob | PRESIDENT AND CEO | Sell 10b5-1 | 34,538 | $12.01 | $414.7K | 621,881 −5.3% of holding | |
| Chacko Jacob | PRESIDENT AND CEO | Sell 10b5-1 | 125,000 | $10.80 | $1.3M | 656,419 −16% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.